LE WE PMID CA
Heart (Atrial fibrillation)6Herz (Vorhofflimmern)

Anticoagulants

Antitachycardia pacing

Autonomous nervous system (Afferents pulmonary)

Cardiovascular risk

Clopidogrel

CNS (Stroke BASKET)

Connexin40

Connexin43

Connexin45

D Dimers

Dabigatran

Defibrillation

Dronedarone

Flecainide

Heart (Arrhythmia)

Heart (Atrial fibrillation)

Heart (Atrial flutter)

Heart (Atrial septum defect)

Heart (Brugada s syndrome)

Heart (Cardiomyopathy dilated)

Heart (Coronary heart disease BASKET)

Heart (CT)

Heart (Echocardiography)

Heart (Electrocardiography)

Heart (Electrophysiological examination)

Heart (Fibrosis)

Heart (MRT)

Heart (Rhythmogenesis)

Heart (Sick sinus syndrome)

Heart (Ventricular fibrillation)

Heart pacemaker (biventricular)

Holt Oram s syndrome

Ibutilide

Ion channel (Sodium)

KCNN3

Long QT syndrome

Nanomedicine

Progressive cardiac conduction disease

Propafenone

Ranolazine

SCN5A

SIDS cot death

Statin

Thyroid (Thyreotoxicosis)

Wolff Parkinson White syndrome

2005  
1
Recent developments in atrial fibrillation.
[15677659] BMJ 330(7485): 238-43 (2005)
1996  
2
ABC of atrial fibrillation. Atrial fibrillation in general and hospital practice.
[8563542] BMJ 312(7024): 175-8 (1996)
1996  
3
ABC of atrial fibrillation. Cardioversion of atrial fibrillation.
[8555897] BMJ 312(7023): 112-5 (1996)
1996  
4
ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation.
[8555864] BMJ 312(7022): 45-9 (1996)
1995  
5
ABC of atrial fibrillation. Drugs for atrial fibrillation.
[8555811] BMJ 311(7020): 1631-4 (1995)
1995  
6
ABC of atrial fibrillation. Investigation and non-drug management of atrial fibrillation.
[8520405] BMJ 311(7019): 1562-5 (1995)
1995  
7
ABC of atrial fibrillation. Differential diagnosis of atrial fibrillation.
[8520345] BMJ 311(7018): 1495-8 (1995)
1995  
8
ABC of atrial fibrillation. Aetiology, pathophysiology, and clinical features.
[8520281] BMJ 311(7017): 1425-8 (1995)
1995  
9
ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation.
[7496293] BMJ 311(7016): 1361-3 (1995)
1999  
10
Practical management of atrial fibrillation.
[10624902] South Med J 92(12): 1136-43 (1999)
1996  
11
Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function.
[8701376] South Med J 89(8): 779-85 (1996)
2008  
12
The impact of statin use on atrial fibrillation.
[18725372] QJM 101(11): 845-61 (2008)
2003  
13
Rate or rhythm control in persistent atrial fibrillation?
[14631054] QJM 96(12): 881-92 (2003)
2001  
14
Paroxysmal atrial fibrillation.
[11744787] QJM 94(12): 665-78 (2001)
2000  
15
Atrial electrical remodelling and atrial fibrillation.
[10984550] QJM 93(9): 563-5 (2000)
2010  
16
Contemporary management of atrial fibrillation: a brief review.
[20639187] Adv Med Sci 55(2): 130-6 (2010)
2007  
17
2008  
18
Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review.
[18362249] Arch Intern Med 168(6): 581-6 (2008)
2006  
19
Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.
[16606807] Arch Intern Med 166(7): 719-28 (2006)
2005  
20
Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis.
[15710787] Arch Intern Med 165(3): 258-62 (2005)
2003  
21
Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis.
[12695268] Arch Intern Med 163(7): 777-85 (2003)
2002  
22
Balancing the risks of stroke and upper gastrointestinal tract bleeding in older patients with atrial fibrillation.
[11871922] Arch Intern Med 162(5): 541-50 (2002)
2007  
23
Atrial fibrillation: insights from clinical trials and novel treatment options.
[18028181] J Intern Med 262(6): 593-614 (2007)
2005  
24
Paroxysmal atrial fibrillation: why patients experience different symptoms from the same arrhythmia?
[15952482] Neth J Med 63(5): 154-5 (2005)
2009  
25
Ablation of atrial fibrillation: what can we tell our patients?
[19726559] Cleve Clin J Med 76(9): 543-50 (2009)
2009  
26
Should catheter ablation be the first line of treatment for atrial fibrillation?
[19726554] Cleve Clin J Med 76(9): 503, 506 (2009)
2003  
27
Managing chronic atrial fibrillation: strategies to control symptoms and prevent embolism.
[12882405] Cleve Clin J Med 70 Suppl 3(-): S30-3 (2003)
2003  
28
Approaches to restoring and maintaining normal sinus rhythm.
[12882404] Cleve Clin J Med 70 Suppl 3(-): S12-29 (2003)
2003  
29
Current clinical issues in atrial fibrillation.
[12882403] Cleve Clin J Med 70 Suppl 3(-): S6-11 (2003)
2003  
30
Basic mechanisms of atrial fibrillation.
[12882402] Cleve Clin J Med 70 Suppl 3(-): S2-5 (2003)
2007  
31
Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients--a clinical framework.
[18036267] Crit Care 11(6): 233 (2007)
2004  
32
Clinical review: clinical management of atrial fibrillation - rate control versus rhythm control.
[15312210] Crit Care 8(4): 271-9 (2004)
2010  
33
Thirty-day outcomes of emergency department patients undergoing electrical cardioversion for atrial fibrillation or flutter.
[20370780] Acad Emerg Med 17(4): 408-15 (2010)
2005  
34
Best evidence topic report. Anticoagulation before cardioversion of acute atrial fibrillation in the emergency department.
[15788833] Emerg Med J 22(4): 275 (2005)
2005  
35
Best evidence topic report. Anticoagulation post-cardioversion of acute atrial fibrillation in the emergency department.
[15788832] Emerg Med J 22(4): 275-6 (2005)
2005  
36
Best evidence topic report: paddle position in emergency cardioversion of atrial fibrillation.
[15611544] Emerg Med J 22(1): 44-6 (2005)
2004  
37
Best evidence topic report. Amiodarone or flecainide for cardioversion in acute onset atrial fibrillation.
[14988348] Emerg Med J 21(2): 199 (2004)
2007  
38
Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis.
[17449500] Heart 93(11): 1433-40 (2007)
2007  
39
Rhythm control and cardioversion.
[16963490] Heart 93(1): 29-34 (2007)
2007  
40
Identification, diagnosis and assessment of atrial fibrillation.
[16952973] Heart 93(1): 25-8 (2007)
2007  
41
Rate control in the medical management of atrial fibrillation.
[16952972] Heart 93(1): 35-8 (2007)
2007  
42
Antithrombotic treatment in atrial fibrillation.
[16952971] Heart 93(1): 39-44 (2007)
2007  
43
Acute management of atrial fibrillation with acute haemodynamic instability and in the postoperative setting.
[16952970] Heart 93(1): 45-7 (2007)
2007  
44
Patient care pathway, implementation and audit criteria for patients with atrial fibrillation.
[16952969] Heart 93(1): 48-52 (2007)
2006  
45
Rhythm control strategies for "symptomatic" persistent atrial fibrillation: is achieving sinus rhythm enough?
[16644853] Heart 92(9): 1189-90 (2006)
2006  
46
Management of atrial fibrillation.
[16844883] Heart 92(8): 1177-82 (2006)
2006  
47
Catheter and surgical ablation of atrial fibrillation.
[16415203] Heart 92(2): 266-74 (2006)
2006  
48
Can we ablate permanent atrial fibrillation?
[16308414] Heart 92(2): 152-4 (2006)
2006  
49
Antithrombotic treatment in atrial fibrillation.
[16159980] Heart 92(2): 155-61 (2006)
2005  
50
Atrial fibrillation ablation in the real world.
[16287725] Heart 91(12): 1507-8 (2005)
2005  
51
Catheter ablation for atrial fibrillation.
[15604320] Heart 91(1): 7-9 (2005)
2004  
52
Theory and practice of defibrillation: (1) Atrial fibrillation and DC conversion.
[15547045] Heart 90(12): 1493-8 (2004)
2004  
53
Importance of using biphasic shock waveforms for cardioversion from atrial fibrillation: an unresolved issue.
[15367497] Heart 90(10): 1105-6 (2004)
2004  
54
Role of oral anticoagulation in management of atrial fibrillation.
[15201261] Heart 90(7): 813-7 (2004)
2003  
55
The role of echocardiography in atrial fibrillation and cardioversion.
[14617563] Heart 89(12): 1447-54 (2003)
2003  
56
Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment.
[12860883] Heart 89(8): 939-43 (2003)
2003  
57
Pacing for atrial fibrillation.
[12482808] Heart 89(1): 106-12 (2003)
2002  
58
Treatment of atrial fibrillation.
[12231613] Heart 88(4): 432-7 (2002)
2002  
59
The right atrium as an anatomic set-up for re-entry: electrophysiology goes back to anatomy.
[12231579] Heart 88(4): 325-7 (2002)
2002  
60
Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation.
[12010934] Heart 87(6): 535-43 (2002)
2002  
61
Current perspectives on curative catheter ablation of atrial fibrillation.
[11751651] Heart 87(1): 6-8 (2002)
2001  
62
Radiofrequency catheter ablation of supraventricular arrhythmias.
[11303019] Heart 85(5): 594-600 (2001)
1998  
63
Atrial fibrillation: towards an understanding of initiation, perpetuation, and specific treatment.
[10065016] Heart 80(6): 533-4 (1998)
1998  
64
Ablate and pace: a pragmatic approach to paroxysmal atrial fibrillation not controlled by antiarrhythmic drugs.
[10078073] Heart 79(6): 531-3 (1998)
1994  
65
Surgery for atrial fibrillation.
[8043325] Br Heart J 71(6): 501-3 (1994)
1993  
66
Antiarrhythmic drugs in the management of atrial fibrillation.
[8217437] Br Heart J 70(4): 304-6 (1993)
1986  
67
The pulse in atrial fibrillation.
[3730201] Br Heart J 56(1): 1-3 (1986)
2004  
68
Radiofrequency ablation for atrial fibrillation: different approaches.
[15353473] Asian Cardiovasc Thorac Ann 12(3): 272-7 (2004)
2003  
69
2010  
70
Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion?
[19942634] Interact Cardiovasc Thorac Surg 10(2): 306-11 (2010)
2009  
71
Atrial fibrillation and acute decompensated heart failure.
[19808318] Circ Heart Fail 2(1): 72-3 (2009)
2009  
72
Managing patients with rapid atrial fibrillation and decompensated heart failure.
[19808317] Circ Heart Fail 2(1): 71 (2009)
1998  
73
Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion?
[9852940] Can J Cardiol 14(10): 1267-73 (1998)
1998  
74
Atrial fibrillation: overview of therapeutic trials.
[9852938] Can J Cardiol 14(10): 1241-54 (1998)
1997  
75
Oral propafenone for rapid conversion of recent onset atrial fibrillation--a review.
[9343033] Can J Cardiol 13(9): 839-42 (1997)
2007  
76
A multiple ion channel blocker, NIP-142, for the treatment of atrial fibrillation.
[18078434] Cardiovasc Drug Rev 25(4): 342-56 (2007)
2009  
77
Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the management of atrial fibrillation.
[19492029] Exp Clin Cardiol 14(1): e1-7 (2009)
2010  
78
Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
[20718760] Cardiovasc Ther 28(5): 295-301 (2010)
2010  
79
New antithrombotics for atrial fibrillation.
[20645985] Cardiovasc Ther 28(5): 278-86 (2010)
2010  
80
Nonpharmacological therapies for atrial fibrillation.
[20626756] Cardiovasc Ther 28(5): 264-77 (2010)
2010  
81
Surgical Maze procedure as a treatment for atrial fibrillation: a meta-analysis of randomized controlled trials.
[20370795] Cardiovasc Ther 28(5): 311-26 (2010)
2010  
82
New approaches to atrial fibrillation management: treat the patient, not the ECG.
[20345495] Cardiovasc Ther 28(5): 302-10 (2010)
2009  
83
Bridging of chronic oral anticoagulation with enoxaparin in patients with atrial fibrillation: results from the prospective BRAVE registry.
[19903186] Cardiovasc Ther 27(4): 230-8 (2009)
2010  
84
Risk factors for atrial fibrillation: Not always severe heart disease, not always so 'lonely'.
[20865672] Cardiol J 17(5): 437-42 (2010)
2009  
85
Is newer better? Propafenone versus quinidine for conversion of atrial fibrillation.
[19950083] Cardiol J 16(6): 491-2 (2009)
2009  
86
Catheter ablation of atrial fibrillation in the elderly: where do we stand?
[19387957] Cardiol J 16(2): 113-20 (2009)
2009  
87
Cardiac resynchronization therapy and atrial fibrillation.
[19130410] Cardiol J 16(1): 4-10 (2009)
2008  
88
Atrial conduction and atrial fibrillation: what can we learn from surface ECG?
[18810714] Cardiol J 15(5): 402-7 (2008)
2008  
89
Non-invasive assessment of atrial electrophysiology: a vital part of the medical work-up in the setting of atrial arrhythmia.
[18651394] Cardiol J 15(2): 97-9 (2008)
2008  
90
Surgical atrial fibrillation ablation: a review of contemporary techniques and energy sources.
[18651392] Cardiol J 15(1): 87-94 (2008)
2009  
91
Is there a role for digoxin in atrial fibrillation without heart failure?
[19753533] Cardiol J 16(5): 483-6 (2009)
2009  
92
Advances in atrial fibrillation ablation.
[19411729] J Invasive Cardiol 21(5): 247-54 (2009)
2009  
93
Chronicling the evolution of catheter ablation for atrial fibrillation and ventricular tachycardia.
[19411727] J Invasive Cardiol 21(5): 239-43 (2009)
2008  
94
Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation.
[18398240] J Invasive Cardiol 20(4): E109-13 (2008)
2004  
95
Right atrial ablation in the management of atrial fibrillation: point of view.
[15353831] J Invasive Cardiol 16(9): 489-92 (2004)
2005  
96
Meta-analysis of clinical outcomes of maze-related surgical procedures for medically refractory atrial fibrillation.
[16143540] Eur J Cardiothorac Surg 28(5): 724-30 (2005)
2005  
97
Surgical treatment of atrial fibrillation; a systematic review.
[15691679] Eur J Cardiothorac Surg 27(2): 258-65 (2005)
2008  
98
Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches.
[18515286] Europace 10(6): 647-65 (2008)
2008  
99
New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'.
[18480076] Europace 10(6): 668-73 (2008)
2008  
100
Novel non-pharmacological approaches for antiarrhythmic therapy of atrial fibrillation.
[18339611] Europace 10(4): 433-7 (2008)
2007  
101
Interatrial conduction in the mechanisms of atrial fibrillation: from anatomy to cardiac signals and new treatment modalities.
[17959684] Europace 9 Suppl 6(-): vi10-6 (2007)
2007  
102
HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society.
[17599941] Europace 9(6): 335-79 (2007)
2006  
103
Analysis of surface electrocardiograms in atrial fibrillation: techniques, research, and clinical applications.
[17043067] Europace 8(11): 911-26 (2006)
2006  
104
The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm.
[16973685] Europace 8(11): 943-9 (2006)
2006  
105
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
[16987906] Europace 8(9): 651-745 (2006)
2005  
106
Anticoagulation in atrial fibrillation and flutter.
[16087116] Europace 7(5): 492-9 (2005)
2004  
107
Contributions of permanent cardiac pacing in the treatment of atrial fibrillation.
[15450278] Europace 5 Suppl 1(-): S36-41 (2004)
2004  
108
Treatment of atrial fibrillation by catheter-based procedures.
[15450277] Europace 5 Suppl 1(-): S30-5 (2004)
2004  
109
Surgical treatment of atrial fibrillation: a review.
[15450276] Europace 5 Suppl 1(-): S20-9 (2004)
2004  
110
Atrial fibrillation and heart failure: natural history and pharmacological treatment.
[15450275] Europace 5 Suppl 1(-): S5-19 (2004)
2003  
111
International consensus on nomenclature and classification of atrial fibrillation; a collaborative project of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.
[12633634] Europace 5(2): 119-22 (2003)
2009  
112
The use of oral ranolazine to convert new or paroxysmal atrial fibrillation: a review of experience with implications for possible "pill in the pocket" approach to atrial fibrillation.
[19763194] Indian Pacing Electrophysiol J 9(5): 260-7 (2009)
2006  
113
Minimally invasive mapping guided surgical treatment of atrial fibrillation. Utopia or near future?
[17031417] Indian Pacing Electrophysiol J 6(4): 234-41 (2006)
2005  
114
Rate-control or rhythm-control: where do we stand?
[16943879] Indian Pacing Electrophysiol J 5(4): 296-304 (2005)
2005  
115
The role of biphasic shocks for transthoracic cardioversion of atrial fibrillation.
[16943878] Indian Pacing Electrophysiol J 5(4): 289-95 (2005)
2004  
116
Evolution of curative therapies for atrial fibrillation review.
[16943884] Indian Pacing Electrophysiol J 4(1): 10-25 (2004)
2008  
117
Evolving strategies in catheter ablation of long-standing atrial fibrillation.
[19808426] Circ Arrhythm Electrophysiol 1(5): 324-6 (2008)
2008  
118
Further insight into the technique and outcomes of "curative" catheter ablation of atrial fibrillation.
[19808415] Circ Arrhythm Electrophysiol 1(4): 238-9 (2008)
2008  
119
Atrial remodeling and atrial fibrillation: mechanisms and implications.
[19808395] Circ Arrhythm Electrophysiol 1(1): 62-73 (2008)
2008  
120
The substrate maintaining persistent atrial fibrillation.
[19808387] Circ Arrhythm Electrophysiol 1(1): 2-5 (2008)
2009  
121
Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS2 score.
[18835820] Eur J Echocardiogr 10(3): 383-8 (2009)
2008  
122
What to do with an atrial thrombus?
[18267926] Eur J Echocardiogr 9(1): 204-5 (2008)
2010  
123
Modern role for clopidogrel in management of atrial fibrillation and stroke reduction.
[20234784] Vasc Health Risk Manag 6(-): 95-103 (2010)
2009  
124
Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation.
[19774220] Vasc Health Risk Manag 5(-): 783-91 (2009)
2009  
125
Dronedarone for atrial fibrillation: a new therapeutic agent.
[19688104] Vasc Health Risk Manag 5(-): 635-42 (2009)
2009  
126
Pleiotropic effects of statins in atrial fibrillation patients: the evidence.
[19590588] Vasc Health Risk Manag 5(3): 533-51 (2009)
2007  
127
2008  
128
Heat shock proteins as molecular targets for intervention in atrial fibrillation.
[18326558] Cardiovasc Res 78(3): 422-8 (2008)
2005  
129
Genetic aspects of atrial fibrillation.
[15921669] Cardiovasc Res 67(3): 414-8 (2005)
2004  
130
Identifying and understanding the role of pulmonary vein activity in atrial fibrillation.
[15537491] Cardiovasc Res 64(3): 387-94 (2004)
2003  
131
New strategies in the surgical treatment of atrial fibrillation.
[12798422] Cardiovasc Res 58(3): 501-9 (2003)
2002  
132
Ablation therapy for atrial fibrillation (AF): past, present and future.
[12062339] Cardiovasc Res 54(2): 337-46 (2002)
2002  
133
Molecular mechanisms of remodeling in human atrial fibrillation.
[12062337] Cardiovasc Res 54(2): 315-24 (2002)
2002  
134
Electrophysiological properties of the human atrium in atrial fibrillation.
[12062336] Cardiovasc Res 54(2): 302-14 (2002)
2002  
135
Thoracic veins and the mechanisms of non-paroxysmal atrial fibrillation.
[12062335] Cardiovasc Res 54(2): 295-301 (2002)
2002  
136
Basic and clinical electrophysiology of pulmonary vein ectopy.
[12062334] Cardiovasc Res 54(2): 287-94 (2002)
2002  
137
Transgenic and knockout mouse models of atrial arrhythmias.
[12062333] Cardiovasc Res 54(2): 280-6 (2002)
2002  
138
Cardiac gap junctions and connexins: their role in atrial fibrillation and potential as therapeutic targets.
[12062332] Cardiovasc Res 54(2): 270-9 (2002)
2002  
139
Cellular electrophysiology of atrial fibrillation.
[12062331] Cardiovasc Res 54(2): 259-69 (2002)
2002  
140
Signal transduction systems and atrial fibrillation.
[12062330] Cardiovasc Res 54(2): 247-58 (2002)
2002  
141
Electrical, contractile and structural remodeling during atrial fibrillation.
[12062329] Cardiovasc Res 54(2): 230-46 (2002)
2002  
142
Mechanisms of atrial flutter and atrial fibrillation: distinct entities or two sides of a coin?
[12062328] Cardiovasc Res 54(2): 217-29 (2002)
2002  
143
Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation.
[12062327] Cardiovasc Res 54(2): 204-16 (2002)
2002  
144
Spotlight on atrial fibrillation-the 'complete arrhythmia'.
[12062326] Cardiovasc Res 54(2): 197-203 (2002)
2001  
145
Establishing the link between a specific pathology and atrial fibrillation.
[11684062] Cardiovasc Res 52(2): 169-70 (2001)
2001  
146
Structural remodelling during chronic atrial fibrillation: act of programmed cell survival.
[11557230] Cardiovasc Res 52(1): 14-24 (2001)
1999  
147
Rate control in atrial fibrillation: role of atrial inputs to the AV node.
[10690301] Cardiovasc Res 44(2): 249-51 (1999)
1999  
148
Atrial fibrillation-induced electrical remodeling in humans: what is the next step?
[10615384] Cardiovasc Res 44(1): 10-2 (1999)
1999  
149
Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation.
[10533568] Cardiovasc Res 42(2): 298-308 (1999)
2008  
150
The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS.
[18782141] Br J Clin Pharmacol 66(3): 345-51 (2008)
2009  
151
Pharmacologic management of atrial fibrillation: established and emerging options.
[19678722] J Manag Care Pharm 15(6 Suppl B): S10-8 (2009)
2007  
152
The use of antithrombotics in patients presenting with stroke and atrial fibrillation.
[18488074] Ther Clin Risk Manag 3(3): 491-8 (2007)
2008  
153
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
[19036232] Health Technol Assess 12(34): iii-iv, xi-xiii, 1-198 (2008)
2006  
154
A new era in the surgical treatment of atrial fibrillation: the impact of ablation technology and lesion set on procedural efficacy.
[16998367] Ann Surg 244(4): 583-92 (2006)
2008  
155
[Anticoagulation in atrial fibrillation].
[18836647] Hamostaseologie 28(4): 213-6 (2008)
2008  
156
The endothelium and atrial fibrillation. The prothrombotic state revisited.
[18836646] Hamostaseologie 28(4): 207-12 (2008)
2008  
157
Initiation and persistence of warfarin or aspirin as thromboprophylaxis in chronic atrial fibrillation in general practice.
[18680537] J Thromb Haemost 6(10): 1622-4 (2008)
2008  
158
Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?
[18573187] J Thromb Haemost 6(9): 1500-6 (2008)
2006  
159
Pharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation: a review.
[16706956] J Thromb Haemost 4(6): 1180-5 (2006)
2005  
160
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome.
[15892862] J Thromb Haemost 3(6): 1218-23 (2005)
2004  
161
Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillation.
[15152749] Am J Manag Care 10(3 Suppl): S72-82 (2004)
2004  
162
Efficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: translating trials into clinical practice.
[15152747] Am J Manag Care 10(3 Suppl): S58-65 (2004)
2004  
163
Epidemiology and management of new-onset atrial fibrillation.
[15152746] Am J Manag Care 10(3 Suppl): S50-7 (2004)
2005  
164
Chessboard of atrial fibrillation: reentry or focus? Single or multiple source(s)? Neurogenic or myogenic?
[16100254] Am J Physiol Heart Circ Physiol 289(3): H977-9 (2005)
2008  
165
2007  
166
Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.
[17577005] Ann Intern Med 146(12): 857-67 (2007)
2003  
167
Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography.
[14678922] Ann Intern Med 139(12): 1018-33 (2003)
2003  
168
Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians.
[14678921] Ann Intern Med 139(12): 1009-17 (2003)
2003  
169
Lessons from the Stroke Prevention in Atrial Fibrillation trials.
[12755555] Ann Intern Med 138(10): 831-8 (2003)
1999  
170
Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention.
[10577332] Ann Intern Med 131(9): 688-95 (1999)
1999  
171
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.
[10507957] Ann Intern Med 131(7): 492-501 (1999)
1997  
172
Management of atrial fibrillation: simplicity surrounded by controversy.
[9027278] Ann Intern Med 126(3): 244-6 (1997)
1996  
173
Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for anticoagulation therapy.
[8678396] Ann Intern Med 125(4): 311-23 (1996)
1994  
174
Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone.
[8311367] Ann Intern Med 120(6): 449-57 (1994)
2005  
175
Surgical ablation of atrial fibrillation.
[16299453] Ann Thorac Cardiovasc Surg 11(5): 285-7 (2005)
2005  
176
1999  
177
When should heparin be given to patients with atrial fibrillation-related embolic brain infarcts?
[10488804] Arch Neurol 56(9): 1059-60 (1999)
2008  
178
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
[18574273] Chest 133(6 Suppl): 546S-592S (2008)
2006  
179
Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation: a useful complement to stroke risk stratification schema.
[17099002] Chest 130(5): 1296-9 (2006)
2005  
180
The pathology of lone atrial fibrillation.
[15705975] Chest 127(2): 424-5 (2005)
2004  
181
Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis.
[15596696] Chest 126(6): 1938-45 (2004)
2000  
182
Medical cardioversion of atrial fibrillation.
[10858374] Chest 117(6): 1529-31 (2000)
1987  
183
Transesophageal pacing in atrial flutter.
[3595247] Chest 92(1): 4-5 (1987)
2009  
184
Does bepridil create a paradigm shift in the treatment of persistent atrial fibrillation?
[19465779] Circ J 73(6): 1008-9 (2009)
2009  
185
How useful is the 3-dimensional image for catheter ablation of atrial fibrillation?
[19246822] Circ J 73(3): 436-7 (2009)
2003  
186
Treatment of paroxysmal atrial fibrillation by pulmonary vein isolation.
[12845176] Circ J 67(7): 567-71 (2003)
2007  
187
Mounting evidence that fibrosis generates a major mechanism for atrial fibrillation.
[17932329] Circ Res 101(8): 743-5 (2007)
2000  
188
Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation.
[10988234] Circ Res 87(6): 440-7 (2000)
2009  
189
Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop.
[19188521] Circulation 119(4): 606-18 (2009)
2008  
190
Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
[18794401] Circulation 118(12): 1285-93 (2008)
2007  
191
Atrial fibrillation-atrial flutter interactions: clinical implications for ablation.
[18071085] Circulation 116(24): 2774-5 (2007)
2007  
192
Genes and atrial fibrillation: a new look at an old problem.
[17698744] Circulation 116(7): 782-92 (2007)
2006  
193
ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
[16908781] Circulation 114(7): e257-354 (2006)
2005  
194
Comparing different strategies for catheter ablation of atrial fibrillation.
[15939829] Circulation 111(22): 2866-8 (2005)
2004  
195
ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation).
[15226233] Circulation 109(25): 3223-43 (2004)
2001  
196
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology.
[11673357] Circulation 104(17): 2118-50 (2001)
2001  
197
Nonpharmacological approaches to atrial fibrillation.
[11319205] Circulation 103(16): 2120-5 (2001)
2001  
198
Pathophysiology and prevention of atrial fibrillation.
[11156892] Circulation 103(5): 769-77 (2001)
1998  
199
New approaches to the management of atrial fibrillation. The role of the atrial defibrillator.
[9778322] Circulation 98(16): 1594-6 (1998)
1998  
200
Low-energy atrial defibrillation: a promising new technique.
[9738635] Circulation 98(9): 833-4 (1998)
1996  
201
Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association.
[8653857] Circulation 93(6): 1262-77 (1996)
2008  
202
Atrial fibrillation subtypes, risk of stroke, and antithrombotic therapy.
[18334477] Eur Heart J 29(7): 840-2 (2008)
2008  
203
Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
[18334476] Eur Heart J 29(7): 915-22 (2008)
2008  
204
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey.
[18270212] Eur Heart J 29(5): 632-9 (2008)
2008  
205
New oral anticoagulants in atrial fibrillation.
[18096568] Eur Heart J 29(2): 155-65 (2008)
2007  
206
From MAZE to ICE: new concepts and new technologies for surgical ablation of atrial fibrillation.
[17984135] Eur Heart J 28(23): 2827-9 (2007)
2007  
207
Outcome parameters for trials in atrial fibrillation: executive summary.
[17897924] Eur Heart J 28(22): 2803-17 (2007)
2007  
208
Management of atrial fibrillation in patients with heart failure.
[17855740] Eur Heart J 28(21): 2568-77 (2007)
2007  
209
Stroke prevention in atrial fibrillation: antiplatelet therapy revisited.
[17430998] Eur Heart J 28(8): 926-8 (2007)
2007  
210
Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis.
[17289748] Eur Heart J 28(4): 457-62 (2007)
2006  
211
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation).
[16885201] Eur Heart J 27(16): 1979-2030 (2006)
2006  
212
Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).
[16847008] Eur Heart J 27(16): 1954-64 (2006)
2006  
213
Anticoagulation for stroke prevention in atrial fibrillation: is gender important?
[16820368] Eur Heart J 27(16): 1893-4 (2006)
2006  
214
Is atrial fibrillation an inflammatory disorder?
[16278230] Eur Heart J 27(2): 136-49 (2006)
2005  
215
Inflammation in the genesis and perpetuation of atrial fibrillation.
[15975993] Eur Heart J 26(20): 2083-92 (2005)
2005  
216
Pulmonary vein stenosis: still the Achilles heel of ablation for atrial fibrillation?
[15911568] Eur Heart J 26(14): 1355-7 (2005)
2005  
217
Towards more effective techniques for catheter ablation of atrial fibrillation: to aim for electrical disconnection of pulmonary veins or not?
[15637088] Eur Heart J 26(7): 627-30 (2005)
2004  
218
Pharmacological cardioversion of recent onset atrial fibrillation.
[15288151] Eur Heart J 25(15): 1274-6 (2004)
2003  
219
Quality of life in nonpharmacologic treatment of atrial fibrillation.
[12909067] Eur Heart J 24(15): 1387-400 (2003)
2001  
220
Transoesophageal echocardiography for immediate and safe cardioversion in patients with atrial fibrillation.
[11686658] Eur Heart J 22(22): 2041-4 (2001)
2001  
221
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology.
[11601835] Eur Heart J 22(20): 1852-923 (2001)
2001  
222
Randomized trial of rhythm or rate control in atrial fibrillation: the Pharmacological Intervention in Atrial Fibrillation Trial (PIAF).
[11350085] Eur Heart J 22(10): 801-2 (2001)
2000  
223
The optimal management of cardioversion of atrial fibrillation or flutter: still a 'stunning' problem.
[10781349] Eur Heart J 21(10): 795-8 (2000)
2000  
224
Systematic review of the management of atrial fibrillation in patients with heart failure.
[10731399] Eur Heart J 21(8): 614-32 (2000)
2000  
225
Cardioversion of chronic atrial fibrillation-towards a more aggressive approach.
[10653670] Eur Heart J 21(4): 263 (2000)
2000  
226
Chronic atrial fibrillation-how to best reach a permanent sinus rhythm?
[10610736] Eur Heart J 21(1): 11-2 (2000)
1998  
227
Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology.
[9792255] Eur Heart J 19(9): 1294-320 (1998)
1998  
228
Anticoagulation for cardioversion of atrial arrhythmias.
[9597402] Eur Heart J 19(4): 548-52 (1998)
1997  
229
Intravenous digoxin: still the drug of choice for acute termination of atrial fibrillation?
[9129879] Eur Heart J 18(4): 546-7 (1997)
1996  
230
Unravelling the electrical mysteries of atrial fibrillation.
[8809533] Eur Heart J 17 Suppl C(-): 2-9 (1996)
2007  
231
The new NICE guideline on atrial fibrillation management.
[16952968] Heart 93(1): 23 (2007)
1998  
232
Problems in the pharmacological evaluation of paroxysmal atrial fibrillation.
[9932625] Intern Med 37(12): 997-8 (1998)
2003  
233
Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
[14645310] JAMA 290(20): 2685-92 (2003)
2001  
234
Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.
[11401607] JAMA 285(22): 2864-70 (2001)
1999  
235
Preventing stroke in patients with atrial fibrillation.
[10340371] JAMA 281(19): 1830-5 (1999)
2009  
236
Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.
[19567719] Mayo Clin Proc 84(7): 643-62 (2009)
2004  
237
The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation.
[15244388] Mayo Clin Proc 79(7): 904-13 (2004)
2002  
238
Direct current cardioversion of atrial fibrillation--the next 40 years.
[12233920] Mayo Clin Proc 77(9): 895-6 (2002)
2000  
239
Atrial fibrillation in dialysis patients.
[10831625] Nephrol Dial Transplant 15(6): 765-8 (2000)
2003  
240
Emergency management of atrial fibrillation.
[12840118] Postgrad Med J 79(932): 313-9 (2003)
2003  
241
Present treatment options for atrial fibrillation.
[12612318] Postgrad Med J 79(928): 67-73 (2003)
1995  
242
Cardioversion of atrial fibrillation.
[7567751] Postgrad Med J 71(838): 457-65 (1995)
2009  
243
Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.
[18757287] Stroke 40(1): 235-40 (2009)
2008  
244
Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians.
[18048861] Stroke 39(1): 227-30 (2008)
2007  
245
Predicting stroke risk in patients with atrial fibrillation.
[17673800] Stroke 38(9): 2409 (2007)
2007  
246
Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation.
[17261703] Stroke 38(2 Suppl): 624-30 (2007)
2007  
247
Advances in surgical treatment of atrial fibrillation.
[17261702] Stroke 38(2 Suppl): 618-23 (2007)
2007  
248
Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm control.
[17261701] Stroke 38(2 Suppl): 615-7 (2007)
2001  
249
Atrial fibrillation and stroke : concepts and controversies.
[11239205] Stroke 32(3): 803-8 (2001)
2000  
250
Underuse of antithrombotic therapy in stroke patients with chronic atrial fibrillation.
[10978142] Stroke 31(9): 2266-7 (2000)
1997  
251
Warfarin use among patients with atrial fibrillation.
[9412618] Stroke 28(12): 2382-9 (1997)
1997  
252
Atrial fibrillation and stroke. Mortality and causes of death after the first acute ischemic stroke.
[9040681] Stroke 28(2): 311-5 (1997)
1990  
253
Thromboembolic complications in atrial fibrillation.
[2405547] Stroke 21(1): 4-13 (1990)
1988  
254
Atrial fibrillation and stroke: new ideas, persisting dilemmas.
[3041652] Stroke 19(8): 937-41 (1988)
2009  
255
Mapping of atrial fibrillation--basic research and clinical applications.
[19736589] Swiss Med Wkly 139(35-36): 496-504 (2009)
2006  
256
Atrial fibrillation: estimated excess rate of stroke due to lacking adherence to guidelines.
[17225195] Swiss Med Wkly 136(47-48): 757-60 (2006)
2000  
257
Atrial fibrillation: the most common arrhythmia.
[11093410] Tex Heart Inst J 27(3): 257-67 (2000)
1999  
258
Low-energy internal cardioversion of atrial fibrillation after failed external cardioversion: Texas Heart Institute experience and review of the literature.
[10397433] Tex Heart Inst J 26(2): 114-9 (1999)
1995  
259
Anticoagulation and atrial fibrillation. Putting the results of clinical trials into practice.
[7571562] West J Med 163(2): 145-52 (1995)
1995  
260
Treatment of nonvalvular atrial fibrillation.
[7747499] West J Med 162(4): 331-9 (1995)
1989  
261
Common causes of cardiac emboli--left ventricular thrombi and atrial fibrillation.
[2672600] West J Med 151(2): 172-9 (1989)
1991  
262
Familial congenital brachial palsy.
[1789287] Am J Med Genet 41(3): 322-4 (1991)
2008  
263
Mystery of biphasic defibrillation waveform efficacy is it calcium?
[18755346] J Am Coll Cardiol 52(10): 836-8 (2008)
2008  
264
Molecular genetics of atrial fibrillation.
[18634977] J Am Coll Cardiol 52(4): 241-50 (2008)
2008  
265
Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials.
[18294568] J Am Coll Cardiol 51(8): 828-35 (2008)
2008  
266
Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.
[18294563] J Am Coll Cardiol 51(8): 802-9 (2008)
2008  
267
Atrial-selective approaches for the treatment of atrial fibrillation.
[18294561] J Am Coll Cardiol 51(8): 787-92 (2008)
2008  
268
Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.
[18174029] J Am Coll Cardiol 51(1): 1-11 (2008)
2007  
269
Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data.
[18021867] J Am Coll Cardiol 50(21): 2021-8 (2007)
2007  
270
Is pulmonary vein antrum isolation a critical determinant of recurrent arrhythmias after ablation of atrial fibrillation?
[17719474] J Am Coll Cardiol 50(9): 875-6 (2007)
2006  
271
Cardiovascular imaging in the management of atrial fibrillation.
[17112997] J Am Coll Cardiol 48(10): 2077-84 (2006)
2006  
272
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).
[16904574] J Am Coll Cardiol 48(4): 854-906 (2006)
2005  
273
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.
[15936615] J Am Coll Cardiol 45(11): 1832-9 (2005)
2004  
274
2004  
275
ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Commitee to Develop Data Standards on Atrial Fibrillation).
[15261958] J Am Coll Cardiol 44(2): 475-95 (2004)
2003  
276
Obliteration of the left atrial appendage for prevention of thromboembolism.
[14522492] J Am Coll Cardiol 42(7): 1259-61 (2003)
2003  
277
Restoring sinus rhythm in atrial fibrillation: a Pyrrhic victory?
[12849655] J Am Coll Cardiol 42(1): 30-2 (2003)
2003  
278
Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis.
[12535819] J Am Coll Cardiol 41(2): 255-62 (2003)
2002  
279
High intensity anticoagulation for cardioversion of atrial arrhythmias? The shocking truth.
[12225718] J Am Coll Cardiol 40(5): 934-6 (2002)
2001  
280
Initial energy setting, outcome and efficiency in direct current cardioversion of atrial fibrillation and flutter.
[11691530] J Am Coll Cardiol 38(5): 1498-504 (2001)
2001  
281
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.
[11583910] J Am Coll Cardiol 38(4): 1231-66 (2001)
2001  
282
Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation.
[11693739] J Am Coll Cardiol 37(3): 691-704 (2001)
2001  
283
Epidemiology and natural history of atrial fibrillation: clinical implications.
[11216949] J Am Coll Cardiol 37(2): 371-8 (2001)
1998  
284
Identification of variables needed to risk adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collection.
[9669281] J Am Coll Cardiol 32(1): 275-82 (1998)
2004  
285
MDCT of the left atrium and pulmonary veins in planning radiofrequency ablation for atrial fibrillation: a how-to guide.
[15333369] AJR Am J Roentgenol 183(3): 767-78 (2004)
2003  
286
Multi-detector row CT of the left atrium and pulmonary veins before radio-frequency catheter ablation for atrial fibrillation.
[14557500] Radiographics 23 Spec No(-): S35-48; discussion S48-50 (2003)
2003  
287
Percutaneous ablation for atrial fibrillation: the role of cross-sectional imaging.
[14557499] Radiographics 23 Spec No(-): S19-33; discussion S48-50 (2003)
2004  
288
2002  
289
New insights into the mechanisms and management of atrial fibrillation.
[12403742] CMAJ 167(9): 1012-20 (2002)
1999  
290
Preventing stroke in atrial fibrillation: why are so many eligible patients not receiving anticoagulant therapy?
[10497611] CMAJ 161(5): 533-4 (1999)
1999  
291
Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
[10497604] CMAJ 161(5): 493-7 (1999)
2011  
292
Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials.
[21411487] BMJ 342(-): d1250 (2011)
2003  
293
Persistent atrial fibrillation: rate control or rhythm control. Rate control is not inferior to rhythm control.
[12829529] BMJ 326(7404): 1411-2 (2003)
2007  
294
Some patients with paroxysmal atrial fibrillation should carry flecainide or propafenone to self treat.
[17379911] BMJ 334(7594): 637 (2007)
2008  
295
Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation.
[18340078] BMJ 336(7644): 614-5 (2008)
2008  
296
Catheter ablation for atrial fibrillation.
[18403546] BMJ 336(7648): 819-26 (2008)
2011  
297
Managing newly diagnosed atrial fibrillation: rate, rhythm, and risk.
[21460131] Cleve Clin J Med 78(4): 258-64 (2011)
2011  
298
Association between CHADS₂risk factors and anticoagulation-related bleeding: a systematic literature review.
[21628615] Mayo Clin Proc 86(6): 509-21 (2011)
2009  
299
Dilemmas in the management of atrial fibrillation in chronic kidney disease.
[19092127] J Am Soc Nephrol 20(4): 705-11 (2009)
2004  
300
Atrial fibrillation: a perspective: thinking inside and outside the box.
[15226225] Circulation 109(25): 3089-95 (2004)
2007  
301
Catheter ablation for atrial fibrillation.
[17893287] Circulation 116(13): 1515-23 (2007)
2009  
302
Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.
[19255343] Circulation 119(10): 1363-9 (2009)
2009  
303
Reducing stroke rates in patients with atrial fibrillation: how low can we go?
[19752317] Circulation 120(13): 1169-70 (2009)
2009  
304
New therapies for stroke prevention in atrial fibrillation: the long road to enhanced efficacy.
[19738132] Circulation 120(12): 1024-6 (2009)
2009  
305
Acute management of atrial fibrillation.
[19265095] Chest 135(3): 849-59 (2009)
2009  
306
The intersection of risk and benefit: is warfarin anticoagulation suitable for atrial fibrillation in patients on hemodialysis?
[19809054] Chest 136(4): 1128-33 (2009)
2005  
307
Atrial fibrillation: multi-detector row CT of pulmonary vein anatomy prior to radiofrequency catheter ablation--initial experience.
[15665218] Radiology 234(3): 702-9 (2005)
2011  
308
Antithrombotic therapy in atrial fibrillation: evaluation and positioning of new oral anticoagulant agents.
[21666370] Circ J 75(7): 1539-47 (2011)
2010  
309
Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): digest version.
[20962419] Circ J 74(11): 2479-500 (2010)
2010  
310
The 2010 update of the ESC guidelines for the management of atrial fibrillation. Beyond the rate or rhythm strategy debate.
[21060204] Circ J 74(12): 2538-41 (2010)
2010  
311
The 2010 update of the ESC guidelines for the management of atrial fibrillation.
[21060205] Circ J 74(12): 2534-7 (2010)
2010  
312
Three-dimensional electroanatomic mapping systems in catheter ablation of atrial fibrillation.
[19920357] Circ J 74(1): 18-23 (2010)
2007  
313
2009  
314
The incidence of ischemic stroke. Paroxysmal Af vs persistent/permanent Af.
[19628920] Circ J 73(8): 1393-4 (2009)
2008  
315
Holt-oram syndrome and atrial fibrillation: opening the (T)-box.
[18535267] Circ Res 102(11): 1304-6 (2008)
2009  
316
The role of connexin40 in atrial fibrillation.
[19535379] Cardiovasc Res 84(1): 15-23 (2009)
2010  
317
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
[20802247] Eur Heart J 31(19): 2369-429 (2010)
2010  
318
Imaging and atrial fibrillation: the role of multimodality imaging in patient evaluation and management of atrial fibrillation.
[20124284] Eur Heart J 31(5): 542-51 (2010)
2007  
319
D-dimers in atrial fibrillation: a further step in risk stratification of thrombo-embolism?
[17716992] Eur Heart J 28(18): 2179-80 (2007)
2009  
320
Atrial fibrillation complicating acute myocardial infarction: how should it be interpreted and how should it be treated and prevented?
[19359325] Eur Heart J 30(9): 1035-7 (2009)
2009  
321
Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications.
[19109347] Eur Heart J 30(9): 1038-45 (2009)
2010  
322
Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation.
[19176537] Eur Heart J 31(8): 967-75 (2010)
2010  
323
The evolving field of stroke prevention in patients with atrial fibrillation.
[20876495] Stroke 41(10 Suppl): S17-20 (2010)
2010  
324
Stroke risk and antithrombotic strategies in atrial fibrillation.
[20930160] Stroke 41(11): 2705-13 (2010)
2007  
325
Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review.
[17901394] Stroke 38(11): 2935-40 (2007)
2008  
326
The balance between stroke prevention and bleeding risk in atrial fibrillation: a delicate balance revisited.
[18323477] Stroke 39(5): 1406-8 (2008)
2008  
327
Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation.
[18420954] Stroke 39(6): 1901-10 (2008)
2009  
328
Optimizing antiplatelet therapy in high-risk patients with atrial fibrillation: insights from Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE A).
[19875732] Stroke 40(12): 3883-5 (2009)
2003  
329
Curative treatment of atrial fibrillation: which is the best technique?
[14768487] Rev Port Cardiol 22(11): 1311-4 (2003)
2007  
330
Atrial fibrillation: from pathophysiology to ablation.
[17939580] Rev Port Cardiol 26(7-8): 707-12 (2007)
2009  
331
Ablation of atrial fibrillation: what is the gold standard strategy?
[20058773] Rev Port Cardiol 28(10): 1043-6 (2009)
2011  
332
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation.
[21138930] Europace 13(2): 161-73 (2011)
2010  
333
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
[20876603] Europace 12(10): 1360-420 (2010)
2010  
334
Genetics of lone atrial fibrillation.
[20823044] Europace 12(10): 1351-2 (2010)
2010  
335
Warfarin in haemodialysis patients with atrial fibrillation: what benefit?
[21045011] Europace 12(12): 1666-72 (2010)
2010  
336
Surgical ablation of lone atrial fibrillation on the beating heart: the chaos continues.
[20139119] Europace 12(3): 297-8 (2010)
2010  
337
Do non-antiarrhythmic drugs have enough pleiotropic power to reduce atrial fibrillation?
[20173204] Europace 12(3): 299-300 (2010)
2010  
338
Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding.
[20388635] Europace 12(6): 761-3 (2010)
2008  
339
Balloon cryoablation for paroxysmal atrial fibrillation.
[18955408] Europace 10(11): 1251-2 (2008)
2008  
340
Imaging of pulmonary veins during catheter ablation for atrial fibrillation: the role of multi-slice computed tomography.
[18955393] Europace 10 Suppl 3(-): iii14-21 (2008)
2008  
341
Imaging in catheter ablation for atrial fibrillation: enhancing the clinician's view.
[18955394] Europace 10 Suppl 3(-): iii2-7 (2008)
2008  
342
Evaluating the left atrium by magnetic resonance imaging.
[18955395] Europace 10 Suppl 3(-): iii22-7 (2008)
2008  
343
Intracardiac echocardiography during catheter ablation of atrial fibrillation.
[18955398] Europace 10 Suppl 3(-): iii42-7 (2008)
2008  
344
Image integration in catheter ablation of atrial fibrillation.
[18955399] Europace 10 Suppl 3(-): iii48-56 (2008)
2008  
345
Managing catheter ablation for atrial fibrillation: the role of echocardiography.
[18955404] Europace 10 Suppl 3(-): iii8-13 (2008)
2010  
346
Pulmonary vein isolation with the pulmonary vein ablation catheter (PVAC): is there a price to pay for a 'simpler', shorter procedure?
[20185487] Europace 12(4): 455-7 (2010)
2010  
347
Animal models for atrial fibrillation: clinical insights and scientific opportunities.
[19875395] Europace 12(2): 160-72 (2010)
2010  
348
Termination of atrial fibrillation by flecainide: mechanistic insights from spectral analysis.
[20167613] Europace 12(4): 453-4 (2010)
2007  
349
Studying atrial fibrillation: what can we learn from the AFTherapy study?
[18042618] Europace 9(12): 1107-9 (2007)
2007  
350
Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association.
[17897925] Europace 9(11): 1006-23 (2007)
2007  
351
Catheter ablation of atrial fibrillation: do we know what we are doing?
[17913698] Europace 9(11): 1002-5 (2007)
2009  
352
Reflections on reconduction after pulmonary vein isolation.
[19307281] Europace 11(4): 400-1 (2009)
2009  
353
Comprehensive upstream treatment for atrial fibrillation, when and how?
[19307280] Europace 11(4): 397-9 (2009)
2008  
354
Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway.
[18308751] Europace 10(3): 294-302 (2008)
2008  
355
Exploring the potential of pulmonary vein recordings: can they help elucidate mechanisms of paroxysmal atrial fibrillation?
[18420651] Europace 10(6): 690-1 (2008)
2009  
356
Cardiac resynchronization therapy in heart failure patients with atrial fibrillation.
[19861396] Europace 11 Suppl 5(-): v82-6 (2009)
2009  
357
Electrophysiological evaluation of pulmonary vein isolation.
[19880409] Europace 11(11): 1423-33 (2009)
2009  
358
Atrial antitachycardia pacing: do we still need to talk about it?
[19589794] Europace 11(8): 977-9 (2009)
2009  
359
How safe is the antiarrhythmic drug therapy in atrial fibrillation?
[19546182] Europace 11(7): 837-9 (2009)
2009  
360
The risk of antiarrhythmic drugs in atrial fibrillation: 20 years of controversies.
[19546183] Europace 11(7): 840-1 (2009)
2010  
361
Management of atrial fibrillation.
[20875341] Discov Med 10(52): 201-8 (2010)
2011  
362
Recent advances in the molecular pathophysiology of atrial fibrillation.
[21804195] J Clin Invest 121(8): 2955-68 (2011)
2003  
363
Atrial fibrillation: new horizons.
[14717205] Chang Gung Med J 26(10): 712-21 (2003)
2008  
364
Surgical treatment of atrial fibrillation with concomitant mitral valve disease: an Asian review.
[19241892] Chang Gung Med J 31(6): 538-45 (2008)
2010  
365
Lenient versus strict rate control in patients with atrial fibrillation.
[20231232] N Engl J Med 362(15): 1363-73 (2010)
2010  
366
Dronedarone for the treatment of atrial fibrillation and atrial flutter.
[21047492] Health Technol Assess 14(Suppl. 2): 55-62 (2010)
2005  
367
Thyrotoxic atrial fibrillation.
[16369379] MedGenMed 7(1): 74 (2005)
2008  
368
2008  
369
Atrial fibrillation (acute onset).
[19450312] Clin Evid (Online) 2008(-): - (2008)
2008  
370
Treating the right patient at the right time: an innovative approach to the management of atrial fibrillation.
[18340388] Can J Cardiol 24(3): 195-8 (2008)
2008  
371
Transcatheter occlusion devices for the prevention of stroke in patients with atrial fibrillation.
[18350780] Hellenic J Cardiol 49(1): 33-6 (2008)
2011  
372
Dronedarone for the management of atrial fibrillation.
[21370206] Swiss Med Wkly 141(-): w13158 (2011)
2010  
373
Cryoballoon ablation for pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
[20407957] Swiss Med Wkly 140(15-16): 214-21 (2010)
2010  
374
Use of the CHADS2 risk score to guide antithrombotic treatment in patients with atrial fibrillation--room for improvement.
[19950036] Swiss Med Wkly 140(5-6): 73-7 (2010)
2011  
375
Learning what works in surgical cryoablation of atrial fibrillation: results of different application techniques and benefits of prospective follow-up.
[21828108] Interact Cardiovasc Thorac Surg 13(5): 480-4 (2011)
2011  
376
The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation.
[21490945] Vasc Health Risk Manag 7(-): 193-202 (2011)
2003  
377
Prediction of atrial fibrillation from surface ECG: review of methods and algorithms.
[14587218] Ann Ist Super Sanita 39(2): 195-203 (2003)
2011  
378
Impact of new criteria for anticoagulant treatment in atrial fibrillation.
[21652133] Rev Esp Cardiol 64(8): 649-53 (2011)
2011  
379
The improved but unfinished business of stroke risk stratification in atrial fibrillation.
[21684058] Rev Esp Cardiol 64(8): 639-41 (2011)
2009  
380
Atrial fibrillation ablation: how far have we come?
[19793512] Rev Esp Cardiol 62(10): 1087-91 (2009)
2010  
381
Radiofrequency ablation in treatment of atrial fibrillation.
[20626219] Physiol Res 59 Suppl 1(-): S43-9 (2010)
2010  
382
New insights into mechanisms of atrial fibrillation.
[19249911] Physiol Res 59(1): 1-12 (2010)
2011  
383
Mechanisms of termination and prevention of atrial fibrillation by drug therapy.
[21334377] Pharmacol Ther 131(2): 221-41 (2011)
2011  
384
Dabigatran as anticoagulant therapy for atrial fibrillation. Which patients should receive it, which patients may not need it, and other practical aspects of patient management.
[21430608] Pol Arch Med Wewn 121(3): 73-80 (2011)
2010  
385
Do specific connection patterns of the ligament of Marshall contribute mechanistically to atrial fibrillation?
[20230909] Heart Rhythm 7(6): 794-5 (2010)
2010  
386
Spatiotemporal and spectral characteristics of atrial fibrillation waves across atrial walls and remodeling.
[20193793] Heart Rhythm 7(4): 518-9 (2010)
2009  
387
Turning on/off the dome in phase 2 reentry: the switching wave hypothesis.
[19467511] Heart Rhythm 6(6): 823-4 (2009)
2007  
388
Triggered activity and atrial fibrillation.
[17336878] Heart Rhythm 4(3 Suppl): S17-23 (2007)
2007  
389
Atrial fibrosis and the mechanisms of atrial fibrillation.
[17336879] Heart Rhythm 4(3 Suppl): S24-7 (2007)
2007  
390
Autonomic nerves in pulmonary veins.
[17336886] Heart Rhythm 4(3 Suppl): S57-60 (2007)
2007  
391
Autonomic nerve activity and atrial fibrillation.
[17336887] Heart Rhythm 4(3 Suppl): S61-4 (2007)
2009  
392
The surgical treatment of atrial fibrillation.
[19631907] Heart Rhythm 6(8 Suppl): S45-50 (2009)
2008  
393
Dynamics factors preceding the initiation of atrial fibrillation in humans.
[18456196] Heart Rhythm 5(6 Suppl): S22-5 (2008)
2008  
394
Genetics of atrial fibrillation: rare mutations, common polymorphisms, and clinical relevance.
[18313611] Heart Rhythm 5(3): 483-6 (2008)
2008  
395
Cardiac fibrillation: from ion channels to rotors in the human heart.
[18468960] Heart Rhythm 5(6): 872-9 (2008)
2002  
396
Atrial fibrillation, the arrhythmia of the elderly, causes and associated conditions.
[12101796] Anadolu Kardiyol Derg 2(1): 55-60 (2002)
2007  
397
Cervical vagosympathetic and mediastinal nerves activation effects on atrial arrhythmia formation.
[17584676] Anadolu Kardiyol Derg 7 Suppl 1(-): 34-6 (2007)
2009  
398
Stroke prevention in atrial fibrillation: WATCHMAN versus warfarin.
[19589108] Expert Rev Cardiovasc Ther 7(7): 727-9 (2009)
2010  
399
Cardiac sodium channelopathies.
[20091048] Pflugers Arch 460(2): 223-37 (2010)
2008  
400
Is there a role for remodeled connexins in AF? No simple answers.
[17935733] J Mol Cell Cardiol 44(1): 4-13 (2008)
2010  
401
Extracellular matrix remodeling in atrial fibrosis: mechanisms and implications in atrial fibrillation.
[19751740] J Mol Cell Cardiol 48(3): 461-7 (2010)
2011  
402
Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation.
[21267357] Drug Des Devel Ther 5(-): 27-39 (2011)
2007  
403
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Negative D-dimer may allow safe early cardioversion of atrial fibrillation.
[17513547] Emerg Med J 24(6): 432-5 (2007)
2004  
404
Recent topics on the surgical treatment for atrial fibrillation.
[15563261] Ann Thorac Cardiovasc Surg 10(5): 277-80 (2004)
2009  
405
Managing atrial fibrillation: catheter ablation or antiarrhythmic therapy?
[20009073] Circ Arrhythm Electrophysiol 2(6): 599-602 (2009)
2009  
406
Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials.
[20009077] Circ Arrhythm Electrophysiol 2(6): 626-33 (2009)
2010  
407
Arrhythmogenic foci and the mechanisms of atrial fibrillation.
[20160176] Circ Arrhythm Electrophysiol 3(1): 7-9 (2010)
2009  
408
Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses.
[19808490] Circ Arrhythm Electrophysiol 2(4): 349-61 (2009)
2009  
409
Atrial fibrillation: focal or reentrant or both?: a new autonomic lens to examine an old riddle.
[19808489] Circ Arrhythm Electrophysiol 2(4): 345-8 (2009)
2009  
410
Present concepts in management of atrial fibrillation: From drug therapy to ablation.
[21160571] World J Cardiol 1(1): 11-22 (2009)
2009  
411
The net clinical benefit of warfarin anticoagulation in atrial fibrillation.
[19721017] Ann Intern Med 151(5): 297-305 (2009)
2004  
412
The changing epidemiology and natural history of nonvalvular atrial fibrillation: clinical implications.
[17060964] Trans Am Clin Climatol Assoc 115(-): 149-59; discussion159-60 (2004)
2011  
413
Recent progress in antithrombotic therapy for atrial fibrillation.
[21088368] J Atheroscler Thromb 18(4): 257-73 (2011)
2011  
414
MDCT in the diagnostic algorithm in patients with symptomatic atrial fibrillation.
[21390192] World J Radiol 3(2): 41-6 (2011)
2009  
415
Management of nonvalvular atrial fibrillation: a comprehensive approach.
[19805924] Indian J Med Sci 63(9): 419-30 (2009)
2010  
416
Recent trends in imaging for atrial fibrillation ablation.
[20473373] Indian Pacing Electrophysiol J 10(5): 215-27 (2010)
2008  
417
Atrial fibrillation after cardiac surgery: where are we now?
[18982137] Indian Pacing Electrophysiol J 8(4): 281-91 (2008)
2011  
418
Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
[21209348] J Am Board Fam Med 24(1): 86-92 (2011)
2010  
419
Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review.
[21118555] J Cardiothorac Surg 5(-): 121 (2010)
2010  
420
Dronedarone in patients with atrial fibrillation.
[20730005] Neth Heart J 18(7-8): 370-3 (2010)
2005  
421
2011  
422
Pharmacological management of atrial fibrillation: one, none, one hundred thousand.
[21577272] Cardiol Res Pract 2011(-): 874802 (2011)
2011  
423
Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?
[21559225] Cardiol Res Pract 2011(-): 752808 (2011)
2011  
424
Surgical treatment of atrial fibrillation: a review.
[21738854] Cardiol Res Pract 2011(-): 214940 (2011)
2011  
425
Management of patients with atrial fibrillation: specific considerations for the old age.
[21860800] Cardiol Res Pract 2011(-): 854205 (2011)
2010  
426
Atrial fibrillation in congestive heart failure.
[20347787] Heart Fail Clin 6(2): 187-200 (2010)
2010  
427
Genetics of atrial fibrillation.
[20347792] Heart Fail Clin 6(2): 239-47 (2010)
2006  
428
Late-phase 3 EAD. A unique mechanism contributing to initiation of atrial fibrillation.
[16606397] Pacing Clin Electrophysiol 29(3): 290-5 (2006)
2009  
429
Current perceptions of the epidemiology of atrial fibrillation.
[19111760] Cardiol Clin 27(1): 13-24, vii (2009)
2009  
430
Genetics of atrial fibrillation.
[19111761] Cardiol Clin 27(1): 25-33, vii (2009)
2009  
431
New concepts in atrial fibrillation: neural mechanisms and calcium dynamics.
[19111762] Cardiol Clin 27(1): 35-43, viii (2009)
2009  
432
Information learned from animal models of atrial fibrillation.
[19111763] Cardiol Clin 27(1): 45-54, viii (2009)
2010  
433
Challenges in the classification of atrial fibrillation.
[20567238] Nat Rev Cardiol 7(8): 451-60 (2010)
2010  
434
New developments in atrial antiarrhythmic drug therapy.
[20179721] Nat Rev Cardiol 7(3): 139-48 (2010)
2009  
435
Recent advances in pharmacotherapy of atrial fibrillation.
[20523864] Indian J Pharmacol 41(4): 153-7 (2009)
2011  
436
Genetics of atrial fibrillation and possible implications for ischemic stroke.
[21822468] Stroke Res Treat 2011(-): 208694 (2011)
2010  
437
Relationship between CHADS2 score and ischemic stroke during rhythm control therapy for paroxysmal atrial fibrillation.
[20145347] Int Heart J 51(1): 24-9 (2010)
2008  
438
New concepts in atrial fibrillation: mechanism and remodeling.
[18060997] Med Clin North Am 92(1): 53-63, x (2008)
2008  
439
2011  
440
Safety and efficacy of dronedarone in the treatment of atrial fibrillation/flutter.
[22084608] Clin Med Insights Cardiol 5(-): 103-19 (2011)
2008  
441
The management of non-valvular atrial fibrillation (NVAF) in Australian general practice: bridging the evidence-practice gap. A national, representative postal survey.
[19014560] BMC Fam Pract 9(-): 62 (2008)
2010  
442
Cardiac adrenergic control and atrial fibrillation.
[19960186] Naunyn Schmiedebergs Arch Pharmacol 381(3): 235-49 (2010)
2010  
443
Common variants in KCNN3 are associated with lone atrial fibrillation.
[20173747] Nat Genet 42(3): 240-4 (2010)
2010  
444
Magnetic nanoparticles and neurotoxins for treating atrial fibrillation: a new way to get burned?
[21135362] Circulation 122(25): 2642-4 (2010)
PMC   
445
Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study.
[23172839] Circulation 127(1):33-8 (2013)
PMC   
446
Atrial fibrillation and microRNAs.
[24478726] Front Physiol 5():15 (2014)
PMC   
447
Echocardiography for left atrial appendage structure and function.
[23102384] Indian Heart J 64(5):469-75 (2012)
PMC   
448
Hybrid surgical and catheter treatment for atrial fibrillation.
[24455303] ISRN Cardiol 2013():920635 (2013)
PMC   
449
PMC   
450
Resolution of left atrial appendage thrombus with apixaban.
[24359320] Thromb J 11(1):26 (2013)
PMC   
451
Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups.
[24455237] Thrombosis 2013():640723 (2013)
PMC   
452
Minimally invasive atrial fibrillation surgery.
[24516812] Ann Cardiothorac Surg 3(1):130 (2014)
PMC   
453
Minimally invasive surgery for atrial fibrillation-Wolf Mini Maze procedure.
[24516810] Ann Cardiothorac Surg 3(1):122-3 (2014)
PMC   
454
Epicardial treatment of concomitant atrial fibrillation in non-mitral valve surgery.
[24516809] Ann Cardiothorac Surg 3(1):120-1 (2014)
PMC   
455
How I do it: minimally invasive Cox-Maze IV procedure.
[24516808] Ann Cardiothorac Surg 3(1):117-9 (2014)
PMC   
456
Illustrated techniques for performing the Cox-Maze IV procedure through a right mini-thoracotomy.
[24516807] Ann Cardiothorac Surg 3(1):105-16 (2014)
PMC   
457
Treatment of lone atrial fibrillation: minimally invasive pulmonary vein isolation, partial cardiac denervation and excision of the left atrial appendage.
[24516806] Ann Cardiothorac Surg 3(1):98-104 (2014)
PMC   
458
Management of refractory atrial fibrillation post surgical ablation.
[24516805] Ann Cardiothorac Surg 3(1):91-7 (2014)
PMC   
459
The definition of success in atrial fibrillation ablation surgery.
[24516804] Ann Cardiothorac Surg 3(1):89-90 (2014)
PMC   
460
A brief overview of surgery for atrial fibrillation.
[24516803] Ann Cardiothorac Surg 3(1):80-8 (2014)
PMC   
461
Breakthroughs in hybrid management of stand-alone AF.
[24516802] Ann Cardiothorac Surg 3(1):78-9 (2014)
PMC   
462
Heart team approach for left atrial appendage therapies: in addition to stroke prevention-is electrical isolation important?
[24516801] Ann Cardiothorac Surg 3(1):75-7 (2014)
PMC   
463
Improvement of left atrial function and left atrial reverse remodeling after surgical treatment of atrial fibrillation.
[24516800] Ann Cardiothorac Surg 3(1):70-4 (2014)
PMC   
464
Performance of the Cox Maze procedure-a large surgical ablation center's experience.
[24516799] Ann Cardiothorac Surg 3(1):62-9 (2014)
PMC   
465
Comparison of the stand-alone Cox-Maze IV procedure to the concomitant Cox-Maze IV and mitral valve procedure for atrial fibrillation.
[24516798] Ann Cardiothorac Surg 3(1):55-61 (2014)
PMC   
466
Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III.
[24516797] Ann Cardiothorac Surg 3(1):45-54 (2014)
PMC   
467
Effectiveness and safety of simultaneous hybrid thoracoscopic and endocardial catheter ablation of lone atrial fibrillation.
[24516796] Ann Cardiothorac Surg 3(1):38-44 (2014)
PMC   
468
Surgical options for treatment of atrial fibrillation.
[24516795] Ann Cardiothorac Surg 3(1):30-7 (2014)
PMC   
469
A systematic review of surgical ablation versus catheter ablation for atrial fibrillation.
[24516794] Ann Cardiothorac Surg 3(1):15-29 (2014)
PMC   
470
Systematic review and meta-analysis of surgical ablation for atrial fibrillation during mitral valve surgery.
[24516793] Ann Cardiothorac Surg 3(1):3-14 (2014)
PMC   
471
Role of late sodium channel current block in the management of atrial fibrillation.
[23108433] Cardiovasc Drugs Ther 27(1):79-89 (2013)
PMC   
472
Comparative effectiveness of dabigatran, rivaroxaban, apixaban, and warfarin in the management of patients with nonvalvular atrial fibrillation.
[23619028] Clin Pharmacol Ther 94(2):269-76 (2013)
PMC   
473
Management of atrial fibrillation in critically ill patients.
[24527212] Crit Care Res Pract 2014():840615 (2014)
PMC   
474
Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysis.
[23299710] Curr Cardiol Rep 15(2):330 (2013)
PMC   
475
A multidisciplinary atrial fibrillation clinic.
[23092274] Curr Cardiol Rev 9(1):55-62 (2013)
PMC   
476
Moving catheter ablation forward from paroxysmal to persistent atrial fibrillation: progress, limitations, and surprises of the SARA trial.
[24371081] Eur Heart J 35(8):482-4 (2014)
PMC   
477
Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices).
[24334432] Eur Heart J 35(8):508-16 (2014)
PMC   
478
Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study).
[24135832] Eur Heart J 35(8):501-7 (2014)
PMC   
479
Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial.
[24072451] Europace 16(2):174-81 (2014)
PMC   
480
Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients.
[24036378] Europace 16(2):195-201 (2014)
PMC   
481
Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
[23878175] Heart 100(4):324-35 (2014)
PMC   
482
Perioperative heart-type fatty acid binding protein levels in atrial fibrillation after cardiac surgery.
[23041578] Heart Rhythm 10(2):153-7 (2013)
PMC   
483
The ABC of a Simple Method for Pulmonary Vein Angiography.
[24493918] Indian Pacing Electrophysiol J 14(1):53-9 (2014)
PMC   
484
Results of clinical application of the modified maze procedure as concomitant surgery.
[23103720] Interact Cardiovasc Thorac Surg 16(2):151-6 (2013)
PMC   
485
Clinical strategies for selecting oral anticoagulants in patients with atrial fibrillation.
[23846737] J Thromb Thrombolysis 36(2):163-74 (2013)
PMC   
486
Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.
[23486416] J Vis Exp (72):e3818 (2013)
PMC   
487
The WATCHMAN left atrial appendage closure device for atrial fibrillation.
[22395336] J Vis Exp (60): (2012)
PMC   
488
Spontaneous, pro-arrhythmic calcium signals disrupt electrical pacing in mouse pulmonary vein sleeve cells.
[24586364] PLoS One 9(2):e88649 (2014)
PMC   
489
Induction of atrial fibrillation by neutrophils critically depends on CD11b/CD18 integrins.
[24558493] PLoS One 9(2):e89307 (2014)
PMC   
490
Clinical characteristics, management, and control of permanent vs. nonpermanent atrial fibrillation: insights from the RealiseAF survey.
[24497948] PLoS One 9(1):e86443 (2014)
PMC   
491
Warfarin and atrial fibrillation: from ideal to real the warfarin affaire.
[24548437] Thromb J 12(1):5 (2014)
PMC   
492
PMC   
493
Rotors and the dynamics of cardiac fibrillation.
[23449547] Circ Res 112(5):849-62 (2013)
PMC   
494
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.
[23223178] Eur J Heart Fail 15(3):324-33 (2013)
PMC   
495
Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins.
[23924190] Antioxid Redox Signal 20(8):1268-85 (2014)
PMC   
496
Refractory atrial fibrillation effectively treated with ranolazine.
[24581108] Indian Heart J 66(1):115-8 (2014)
PMC   
497
Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk.
[24648742] Vasc Health Risk Manag 10():101-14 (2014)
PMC   
498
Isolated insular strokes and plasma MR-proANP levels are associated with newly diagnosed atrial fibrillation: a pilot study.
[24647802] PLoS One 9(3):e92421 (2014)
PMC   
499
Dronedarone-current status in management of atrial fibrillation.
[22572497] Indian Heart J 64(2):182-6 (2012)
PMC   
500
Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation.
[24651058] Med Sci Monit 20():463-70 (2014)
PMC   
501
Dronedarone in high-risk permanent atrial fibrillation.
[C3860949] Indian Heart J 64(1):112 (2012)
PMC   
502
Left atrial appendage exclusion--Where do we stand?
[24672702] J Thorac Dis 6(Suppl 1):S70-7 (2014)
PMC   
503
New Oral Anticoagulants for Atrial Fibrillation: Are They Worth the Risk?
[24672216] P T 39(1):54-64 (2014)
PMC   
504
Ablation technology for the surgical treatment of atrial fibrillation.
[23995989] ASAIO J 59(5):461-8 (2013)
PMC   
505
Thromboembolism Prevention via Transcatheter Left Atrial Appendage Closure with Transeosophageal Echocardiography Guidance.
[24672720] Thrombosis 2014(): (2014)
PMC   
506
Multi-channel blockers for treatment of atrial fibrillation: an effective strategy?
[23455549] Cardiovasc Res 98(1):5-6 (2013)
PMC   
507
Score for atrial fibrillation detection in acute stroke and transient ischemic attack patients in a Brazilian population: the acute stroke atrial fibrillation scoring system.
[24714831] Clinics (Sao Paulo) 69(4):241-6 (2014)
PMC   
508
Paired-like homeodomain 2: a novel therapeutic target for atrial fibrillation?
[24782888] Front Genet 5():74 (2014)
PMC   
509
ENGAGE AF: Effective anticoagulation with factor Xa in next generation treatment of atrial fibrillation.
[24749107] Glob Cardiol Sci Pract 2013(4):354-6 (2013)
PMC   
510
Heterogeneous and anisotropic integrative model of pulmonary veins: computational study of arrhythmogenic substrate for atrial fibrillation.
[24427522] Interface Focus 3(2):20120069 (2013)
PMC   
511
Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke.
[23535493] Neurology 80(17):1546-50 (2013)
PMC   
512
Atrial fibrillation-linked germline GJA5/connexin40 mutants showed an increased hemichannel function.
[24733048] PLoS One 9(4):e95125 (2014)
PMC   
513
Atrial fibrillation is associated with reduced brain volume and cognitive function independent of cerebral infarcts.
[23444303] Stroke 44(4):1020-5 (2013)
PMC   
514
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation.
[24711702] Ther Clin Risk Manag 10():197-205 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


  • Zerebrale Ischämie: Primär- und Sekundärprävention


  • Search PubMed and many other databases on the combined search terms

    GG: atrial fibrillation

  • Herz (Vorhofflimmern)

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia